German Machinery Stock News

M1 Kliniken (XTRA:M12) has put solid numbers on the table for FY 2025, with first half revenue of €183.5 million and EPS of €0.63 supported by net income of €11.6 million, while the trailing 12 months show revenue of €365.5 million and EPS of €1.19 backed by €22.1 million of net income. The company has seen revenue move from €339.2 million on a trailing 12 month basis in the second half of 2024 to €365.5 million most recently, and EPS over that same trailing period shift from €0.85 to €1.19...

If you are wondering whether SAP at €150.90 is a bargain or still looks expensive, the key is understanding what the current price is really paying for. The stock has risen 6.9% over the last week, is roughly flat over the last month with a decline of 0.2%, but is still down 25.3% year to date and 42.2% over the last year. This sits against longer term returns of 29.8% over three years and 43.8% over five years. These swings have kept SAP on many watchlists, with investors reacting to...

In May 2026, Siemens Energy AG reported half-year sales of €19,969 million and net income of €1,443 million, with earnings per share from continuing operations more than doubling year-on-year, and simultaneously raised its 2026 comparable revenue growth guidance to 14%–16%. Alongside these results, the company has been executing an ongoing share buyback program that has already retired over 12 million shares since March 2026, highlighting how earnings strength is being paired with active...

Why TUI's latest earnings matter for shareholders TUI (XTRA:TUI1) has drawn fresh attention after reporting second quarter and six month results to March 31, 2026, showing relatively steady sales and narrower net losses compared with the previous year. See our latest analysis for TUI. The 1 day share price return of 2.96% takes TUI to €6.536, but weaker 30 day and year to date share price returns show momentum has faded even as recent earnings pointed to reduced net losses. If this earnings...

Gerresheimer (XTRA:GXI) has drawn investor attention after recent share price moves, with the stock up about 22% over the past month and roughly 24% in the past 3 months from its last close of €25.88. See our latest analysis for Gerresheimer. The recent 21.96% 1 month share price return and 24.07% 3 month share price return sit against a year to date share price decline of 6.91% and a 1 year total shareholder return decline of 57.54%. This indicates that short term momentum is building while...

Why SCHOTT Pharma KGaA’s Latest Earnings Matter for the Stock SCHOTT Pharma KGaA (XTRA:1SXP) released second quarter and six month results to March 31, 2026, reporting relatively stable sales but lower net income and earnings per share compared with the prior year period. See our latest analysis for SCHOTT Pharma KGaA. The earnings release arrived after a weak year for investors, with a 1-year total shareholder return that declined 43.69%, even as share price momentum has recently improved...

Volkswagen is expanding vehicle assembly in Uzbekistan, supporting the country's goal of becoming a Central Asian auto hub. At the same time, the company is facing tougher competition in Brazil as Chinese automakers increase their presence, especially in electric and hybrid models. For investors tracking XTRA:VOW3, these moves come as the stock trades around €87.92 and has been under pressure over longer periods. The share price is down 17.4% year to date and has declined 38.2% over five...

The Health Impact Alliance has selected Infineon Technologies (XTRA:IFX) to supply connectivity and edge AI chips for a wide range of senior care devices, putting the stock’s healthcare exposure firmly in focus. See our latest analysis for Infineon Technologies. That healthcare deal lands at a time when momentum in the stock has been strong, with a 30 day share price return of 41.56% and a year to date share price return of 77.55%, while the 1 year total shareholder return of 97.56% points to...

As European markets navigate geopolitical tensions and inflationary pressures, the pan-European STOXX Europe 600 Index has seen a recent decline, reflecting broader economic concerns. In this environment, dividend stocks can offer investors a measure of stability through consistent income streams, making them an attractive consideration amid market volatility.

The subdued market reaction suggests that Hapag-Lloyd Aktiengesellschaft's ( ETR:HLAG ) recent earnings didn't contain...

It looks like Fresenius SE & Co. KGaA ( ETR:FRE ) is about to go ex-dividend in the next 3 days. The ex-dividend date...

Porsche (XTRA:P911) is restructuring its Executive Board, integrating its Car IT division into Research & Development. The company is pushing ahead with new digital in car experiences, including dedicated software interfaces for the Chinese market. The changes focus on tightening the link between vehicle engineering, software, and connectivity features across the product range. Porsche, known for its sports cars and performance focused SUVs, is putting software and digital features closer...

Mercedes-Benz Group (XTRA:MBG) has been on many watchlists after a period of weaker share performance, with the stock down about 6% over the past month and roughly 17% in the past 3 months. See our latest analysis for Mercedes-Benz Group. Recent trading has been weak, with the stock down about 6% on a 30 day share price return and roughly 20% year to date, while the 1 year total shareholder return is close to flat. This suggests momentum has faded compared with longer term gains over 5...

Deutsche Telekom and LogicMonitor are expanding their partnership to deliver an AI first managed services platform across continental Europe. The rollout will cover DACH, Benelux, and Nordic regions, targeting complex hybrid IT and network environments for enterprise customers. The move aims to improve visibility and predictive resilience for clients undergoing digital transformation projects. XTRA:DTE is trading at around €29.38, with the stock up 6.4% over the past week and 5.6% year to...

As European markets navigate the complexities of geopolitical tensions and inflationary pressures, the pan-European STOXX Europe 600 Index recently experienced a slight decline. Despite these challenges, robust corporate earnings growth across the region highlights potential opportunities for investors seeking to explore small-cap stocks with promising prospects. Identifying such stocks often involves looking for companies demonstrating resilience and innovation in their sectors, particularly...

As European markets navigate the challenges of geopolitical tensions and rising energy prices, investors are increasingly focused on stable income sources amidst economic uncertainties. In this context, dividend stocks can be appealing for their potential to provide consistent returns through regular payouts, making them a key consideration in today's market environment.

The key driver for Bayer (XTRA:BAYN) today is the FDA granting Priority Review to two investigational drugs: HYRNUO for certain HER2 mutated lung cancers, and asundexian for secondary stroke prevention, spotlighting its late stage pipeline. See our latest analysis for Bayer. That regulatory momentum comes after a weak patch for the stock, with the 30 day share price return down 6.28% and the 90 day share price return down 15.91%, even as the 1 year total shareholder return is 64.88%. If this...

Market reaction to strike driven passenger drop Fraport (XTRA:FRA) is in focus after reporting an 11% year-on-year decline in April passenger volumes at Frankfurt Airport, linked to six strike days that disrupted roughly half a million travellers. See our latest analysis for Fraport. The recent strikes come against a weaker price backdrop, with the 30 day share price return down 16.57% and the 90 day share price return down 22.47%, even as the 1 year total shareholder return is 11.28%. If...

In May 2026, the European stock market is navigating a complex environment marked by geopolitical tensions and inflationary pressures due to rising energy costs. Despite these challenges, robust corporate earnings growth in the region suggests potential opportunities for investors seeking stocks that may be trading below their fair value. In such a climate, identifying undervalued stocks involves looking for companies with strong fundamentals and resilience to external pressures, which can...

Nemetschek (XTRA:NEM) moved higher after weaker UK jobs data cooled expectations for further Bank of England rate hikes. This lifted European growth stocks as investors responded to the prospect of less aggressive monetary tightening. See our latest analysis for Nemetschek. Despite the 10.02% 1 day share price return to €65.9 and a 9.11% 7 day share price return, momentum has been fading. The year to date share price return is down 27.02% and the 1 year total shareholder return has declined...

Instone Real Estate Group SE's ( ETR:INS ) robust recent earnings didn't do much to move the stock. We believe that...

CENIT Aktiengesellschaft's ( ETR:CSH ) strong earnings report was rewarded with a positive stock price move. We have...

Merck KGaA (XTRA:MRK) has been in focus after recent value oriented analyst coverage and the announcement of a five year agreement with Genetix Biotherapeutics, covering testing services for FDA approved gene therapies. See our latest analysis for Merck KGaA. Recent news, including the Genetix agreement and first quarter earnings, has coincided with a 6.50% 7 day share price return to €120.35. However, the 90 day share price return declined 6.38% and the 3 year total shareholder return is...

Fresenius SE KGaA (XTRA:FRE) has drawn fresh attention after reporting first quarter 2026 results and aligning these figures with a new investment in Avelios Medical together with technology partner SAP. See our latest analysis for Fresenius SE KGaA. The share price has recently come under pressure, with a 30 day share price return down 11.14% and a 90 day share price return down 23.49%. This comes even though the 3 year total shareholder return is up 48.03% and the 1 year total shareholder...